Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1986 1
1987 1
1988 4
1989 5
1990 4
1991 13
1992 4
1993 17
1994 14
1995 9
1996 7
1997 5
1998 9
1999 7
2000 17
2001 15
2002 8
2003 9
2004 8
2005 13
2006 10
2007 14
2008 14
2009 20
2010 10
2011 14
2012 12
2013 12
2014 7
2015 11
2016 14
2017 13
2018 14
2019 18
2020 17
2021 18
2022 14
2023 9
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

392 results

Results by year

Filters applied: . Clear all
Page 1
Ovarian Cancer Immunotherapy and Personalized Medicine.
Morand S, Devanaboyina M, Staats H, Stanbery L, Nemunaitis J. Morand S, et al. Among authors: nemunaitis j. Int J Mol Sci. 2021 Jun 18;22(12):6532. doi: 10.3390/ijms22126532. Int J Mol Sci. 2021. PMID: 34207103 Free PMC article. Review.
siRNA vs. shRNA: similarities and differences.
Rao DD, Vorhies JS, Senzer N, Nemunaitis J. Rao DD, et al. Among authors: nemunaitis j. Adv Drug Deliv Rev. 2009 Jul 25;61(9):746-59. doi: 10.1016/j.addr.2009.04.004. Epub 2009 Apr 20. Adv Drug Deliv Rev. 2009. PMID: 19389436 Review.
Sipuleucel-T immunotherapy for castration-resistant prostate cancer.
Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, Redfern CH, Ferrari AC, Dreicer R, Sims RB, Xu Y, Frohlich MW, Schellhammer PF; IMPACT Study Investigators. Kantoff PW, et al. N Engl J Med. 2010 Jul 29;363(5):411-22. doi: 10.1056/NEJMoa1001294. N Engl J Med. 2010. PMID: 20818862 Free article. Clinical Trial.
AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer.
Hong D, Kurzrock R, Kim Y, Woessner R, Younes A, Nemunaitis J, Fowler N, Zhou T, Schmidt J, Jo M, Lee SJ, Yamashita M, Hughes SG, Fayad L, Piha-Paul S, Nadella MV, Mohseni M, Lawson D, Reimer C, Blakey DC, Xiao X, Hsu J, Revenko A, Monia BP, MacLeod AR. Hong D, et al. Among authors: nemunaitis j. Sci Transl Med. 2015 Nov 18;7(314):314ra185. doi: 10.1126/scitranslmed.aac5272. Sci Transl Med. 2015. PMID: 26582900 Free PMC article. Clinical Trial.
Advances in Targeted Therapy for the Treatment of Cervical Cancer.
Watkins DE, Craig DJ, Vellani SD, Hegazi A, Fredrickson KJ, Walter A, Stanbery L, Nemunaitis J. Watkins DE, et al. Among authors: nemunaitis j. J Clin Med. 2023 Sep 15;12(18):5992. doi: 10.3390/jcm12185992. J Clin Med. 2023. PMID: 37762931 Free PMC article. Review.
The abscopal effect of radiation therapy.
Craig DJ, Nanavaty NS, Devanaboyina M, Stanbery L, Hamouda D, Edelman G, Dworkin L, Nemunaitis JJ. Craig DJ, et al. Among authors: nemunaitis jj. Future Oncol. 2021 May;17(13):1683-1694. doi: 10.2217/fon-2020-0994. Epub 2021 Mar 17. Future Oncol. 2021. PMID: 33726502 Free article. Review.
Folate Receptor as a Biomarker and Therapeutic Target in Solid Tumors.
Young O, Ngo N, Lin L, Stanbery L, Creeden JF, Hamouda D, Nemunaitis J. Young O, et al. Among authors: nemunaitis j. Curr Probl Cancer. 2023 Feb;47(1):100917. doi: 10.1016/j.currproblcancer.2022.100917. Epub 2022 Nov 17. Curr Probl Cancer. 2023. PMID: 36508886 Free article. Review.
Smart exosomes enhance PDAC targeted therapy.
Creeden JF, Sevier J, Zhang JT, Lapitsky Y, Brunicardi FC, Jin G, Nemunaitis J, Liu JY, Kalinoski A, Rao D, Liu SH. Creeden JF, et al. Among authors: nemunaitis j. J Control Release. 2024 Apr;368:413-429. doi: 10.1016/j.jconrel.2024.02.037. Epub 2024 Mar 7. J Control Release. 2024. PMID: 38431093 Free article.
Harnessing the immune response to target tumors.
Manning L, Nemunaitis J. Manning L, et al. Among authors: nemunaitis j. F1000Res. 2017 May 18;6:710. doi: 10.12688/f1000research.10795.1. eCollection 2017. F1000Res. 2017. PMID: 28620466 Free PMC article. Review.
Oncolytic viruses.
Nemunaitis J. Nemunaitis J. Invest New Drugs. 1999;17(4):375-86. doi: 10.1023/a:1006334404767. Invest New Drugs. 1999. PMID: 10759404 Review.
392 results